HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GnRH receptor antagonists for prostate cancer.

Abstract
GnRH receptor antagonists can reduce testosterone levels without the adverse reactions caused by other drugs used to treat prostate cancer. These drugs also offer hope for prolonged control of metastasis.
AuthorsEmily Patrick, Melissa Whitson, Amy Smith, Jamin Parnell, Suzanne E Thomas, Clint C Blankenship
JournalJAAPA : official journal of the American Academy of Physician Assistants (JAAPA) Vol. 26 Issue 7 Pg. 51-2 (Jul 2013) ISSN: 1547-1896 [Print] United States
PMID23923287 (Publication Type: Journal Article, Review)
Chemical References
  • Receptors, LHRH
  • Gonadotropin-Releasing Hormone
Topics
  • Gonadotropin-Releasing Hormone (antagonists & inhibitors, therapeutic use)
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy)
  • Receptors, LHRH (antagonists & inhibitors, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: